Construction and Characterization of the Mycobacterium tuberculosis sigE fadD26 Unmarked Double Mutant as a Vaccine Candidate-Reference-Cited by-同舟云学术

Construction and Characterization of the Mycobacterium tuberculosis sigE fadD26 Unmarked Double Mutant as a Vaccine Candidate

Published:2019-12-17 Issue:1 Volume:88 Page:
ISSN:0019-9567
Container-title:Infection and Immunity
language:en
Short-container-title:Infect Immun

Author:

Hernandez-Pando Rogelio¹,Shin Sung Jae²,Clark Simon³,Casonato Stefano⁴,Becerril-Zambrano Martin¹,Kim Hongmin²,Boldrin Francesca⁴,Mata-Espinoza Dulce¹,Provvedi Roberta⁵,Arbues Ainhoa⁶,Marquina-Castillo Brenda¹,Cioetto Mazzabò Laura⁴,Barrios-Payan Jorge¹,Martin Carlos⁶,Cho Sang-Nae²,Williams Ann³,Manganelli Riccardo⁴

Affiliation:

1. Experimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition Salvador Zubiràn, Mexico City, Mexico

2. Department of Microbiology, Institute for Immunology and Immunological Disease, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea

3. Public Health England, Microbiology Services, Porton Down, Salisbury, Wiltshire, United Kingdom

4. Department of Molecular Medicine, University of Padova, Padua, Italy

5. Department of Biology, University of Padova, Padua, Italy

6. Departamento de Microbiología, Facultad de Medicina, Universidad de Zaragoza, Zaragoza, Spain

Abstract

Despite the great increase in the understanding of the biology and pathogenesis of Mycobacterium tuberculosis achieved by the scientific community in recent decades, tuberculosis (TB) still represents one of the major threats to global human health.

Funder

Department of Health, UK

Science and Technology Institute of Mexico City

European Commission

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Immunology,Microbiology,Parasitology

Link

https://journals.asm.org/doi/pdf/10.1128/IAI.00496-19

Reference37 articles.

1. Exacting Edward Jenner’s revenge: The quest for a new tuberculosis vaccine